Doctors are not safe with some patients.

Published Date: 16 Feb 2023

Many physicians have encountered one or more serious or potentially dangerous patients over the years, and according to Medscape research, patient trust has declined.

Read Full News

Latest News

Trump's Push for the World's Lowest Drug Prices Hits Snag With Mid-sized Companies

President Donald Trump has promised to make U.S. prescription drug prices the cheapest in the world, but a closely watched Medicaid pilot program could expose the limits of...

Experimental Novartis Radiopharma Drug Shows Promise in Early Study

Novartis said on Sunday that early data from its experimental actinium-based drug showed signs of anti-tumour activity against prostate cancer, including in ⁠patients...

Vasectomy Reversal More Cost-Effective Than IVF

Most couples younger than 40 years can achieve pregnancy within typical $30,000-$40,000 employer fertility benefits with reversal, new research indicates.

US Judge Rejects Bayer Bid to Block Johnson & Johnson Prostate Cancer Drug Claims

A U.S. judge has rejected Bayer's request for an injunction to block Johnson & Johnson's alleged false advertising that ⁠its multibillion-dollar drug cuts the risk of...

This Test Could Predict Incontinence Risk After HoLEP

Men with a shorter membranous urethra appear more likely to experience urinary incontinence after laser enucleation for benign prostatic hyperplasia, a new study shows.

Smartphone App Helps Delay Ejaculation

The app improves sexual control and doubles ejaculation latency time in a randomized trial.

Todays Updates

Asian Women With Breast Cancer Outlive White Peers

Researchers seek to understand why Asian women fare better with the disease.

FDA Approves Orca‑T, a Next‑Gen HSCT to Reduce GVHD

By carefully controlling the mix of stem and T cells, Orca‑T lowers the risk for graft-vs-host disease in adults with hematologic cancers.

Todays Updates

Asian Women With Breast Cancer Outlive White Peers

Researchers seek to understand why Asian women fare better with the disease.

FDA Approves Orca‑T, a Next‑Gen HSCT to Reduce GVHD

By carefully controlling the mix of stem and T cells, Orca‑T lowers the risk for graft-vs-host disease in adults with hematologic cancers.

Latest News

President Donald Trump has promised to make U.S. prescription drug prices the cheapest in the world, but a closely watched Medicaid pilot program could expose the limits of...

Novartis said on Sunday that early data from its experimental actinium-based drug showed signs of anti-tumour activity against prostate cancer, including in ⁠patients...

Most couples younger than 40 years can achieve pregnancy within typical $30,000-$40,000 employer fertility benefits with reversal, new research indicates.

A U.S. judge has rejected Bayer's request for an injunction to block Johnson & Johnson's alleged false advertising that ⁠its multibillion-dollar drug cuts the risk of...

Men with a shorter membranous urethra appear more likely to experience urinary incontinence after laser enucleation for benign prostatic hyperplasia, a new study shows.

The app improves sexual control and doubles ejaculation latency time in a randomized trial.

News All Time

Weary of Prior Auths? What Would Happen If You Were Paid by the Insurers to Submit Them?

Approving a prior authorization CPT code is what the NYC urologist is requesting.

FDA Approves New Treatment for Women's Simple UTIs.

Now available in the U.S. is an antibiotic that is widely used in other nations. s.

During the Accountable Care Meeting, CMS Officials were pressed on the topic of scanner fraud.

"We would appreciate it if you could give the matter more immediate attention," one ACO member said.

Nivolumab Plus Chemotherapy in First Line Approved for Bladder Cancer.

Combination decreased death risk by 22%.

King Charles III's Operation; COVID-19 Timeline Under Question; FDA Approvals Reach Record High.

The staff of MedPage Today has compiled health news and commentary from around the web.

Noninvasive Treatment Effective in Bladder Cancer That Is Not Muscle-Invasive.

An investigational intrusive solution produced a 79% complete response rate.

For Prostate Cancer at Intermediate Risk, SBRT Is Not Less Effective Than Conventional RT.

Similar results are obtained from treatment lasting one to two weeks as compared to therapy lasting up to seven and a half weeks.

Even in those with HIV, a single dose of antibiotics was able to cure early syphilis.

In a randomized trial, one dosage showed no worse results than a triple-dose regimen.

Should Patients With Advanced Prostate Cancer Get Off the Active Surveillance Train?

Clearly defined rules are needed.

The new first-line standard for advanced bladder cancer was produced by a landmark trial.

When compared to chemotherapy, enfortumab vedotin-pembrolizumab doubles OS and PFS.

AR-Pathway Inhibitor Switch for mCRPC is Superseded by Radionuclide Therapy.

With 177Lu-PSMA-617, the time to radiographic progression was doubled.

An RCT Supports HIF-2a Inhibition in Advanced RCC.

Belzutifan outperforms everolimus in the event of immunotherapy-TKI failure.

Cabazitaxel Lower-Dose Schedule Is Viable for Elderly Patients With mCRPC.

Neutropenia of grade three or above, with a twelve-fold reduction in neutropenic consequences.

Removing Cancer Survivors From Oncologic Treatment.

A new approach to care is required.

CAR T-Cell Therapy for Renal Cell Carcinoma: "We're Not There Yet".

Possibility of standard of care following current therapies, but significant barriers still need to be overcome.

In severe cases of renal cell carcinoma, tyrosine kinase inhibitor activity is present.

Reactions to the "special medication" zanzalintinib in patients exposed and not exposed to cabozantinib.

Breast Cancer Incidence Increased Due to Particulate Air Pollution, According to NIH Study.

Insurance Claim Denials for Preventive Care More Common in At-Risk Patients

Participate and win cash vouchers

Get updates on the latest events happening around the world

2.

Novel Mimetic Bispecific Antibody Superior to Standard Care in Hemophilia A

3.

Advanced Solid Tumors May Benefit from Investigative Immunotherapy Combo.

4.

New opportunities for screening and treatment have been created by the identification of the genetic drivers of esophageal cancer.

5.

For treatment, the majority of cancer patients choose complementary therapies.

1.

Revolutionizing Cancer Treatment: The Promise of Bevacizumab Injections

2.

Real-World Evidence and Patient Voices: Redefining Outcomes in Modern Oncology

3.

Uncovering the Mysteries of Breast Cancer: The Journey to a Cure

4.

The Crucial Role of Antithrombin 3 in Preventing Blood Clots: A Comprehensive Guide

5.

Adaptive Rehabilitation Strategies for Advanced Cancer Survivorship

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

Preventing Blood Clots: The Importance of Venous Thromboembolism Management

2.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part I

3.

Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion

4.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VI

5.

Navigating the Complexities of Ph Negative ALL - Part IV

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug Database Drug Interaction Diseases Database

KOL Videos Knowledge Hub Quizzes

Medical Updates Events About Us

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation

Doctors are not safe with some patients.

Latest News

Trump's Push for the World's Lowest Drug Prices Hits Snag With Mid-sized Companies

Experimental Novartis Radiopharma Drug Shows Promise in Early Study

Vasectomy Reversal More Cost-Effective Than IVF

US Judge Rejects Bayer Bid to Block Johnson & Johnson Prostate Cancer Drug Claims

This Test Could Predict Incontinence Risk After HoLEP

Smartphone App Helps Delay Ejaculation

Todays Updates

Asian Women With Breast Cancer Outlive White Peers

FDA Approves Orca‑T, a Next‑Gen HSCT to Reduce GVHD

Todays Updates

Asian Women With Breast Cancer Outlive White Peers

FDA Approves Orca‑T, a Next‑Gen HSCT to Reduce GVHD

Latest News

News All Time

Weary of Prior Auths? What Would Happen If You Were Paid by the Insurers to Submit Them?

FDA Approves New Treatment for Women's Simple UTIs.

During the Accountable Care Meeting, CMS Officials were pressed on the topic of scanner fraud.

Nivolumab Plus Chemotherapy in First Line Approved for Bladder Cancer.

King Charles III's Operation; COVID-19 Timeline Under Question; FDA Approvals Reach Record High.

Noninvasive Treatment Effective in Bladder Cancer That Is Not Muscle-Invasive.

For Prostate Cancer at Intermediate Risk, SBRT Is Not Less Effective Than Conventional RT.

Even in those with HIV, a single dose of antibiotics was able to cure early syphilis.

Should Patients With Advanced Prostate Cancer Get Off the Active Surveillance Train?

The new first-line standard for advanced bladder cancer was produced by a landmark trial.

AR-Pathway Inhibitor Switch for mCRPC is Superseded by Radionuclide Therapy.

An RCT Supports HIF-2a Inhibition in Advanced RCC.

Cabazitaxel Lower-Dose Schedule Is Viable for Elderly Patients With mCRPC.

Removing Cancer Survivors From Oncologic Treatment.

CAR T-Cell Therapy for Renal Cell Carcinoma: "We're Not There Yet".

In severe cases of renal cell carcinoma, tyrosine kinase inhibitor activity is present.

Recommended News For You

Six breast texture patterns linked to higher risk of invasive cancer

Pickleball program boosts health and wellness for cancer survivors, study finds

Dual-action mRNA vaccine takes aim at aggressive skin cancer

A radiotheranostic approach designed to combat aggressive cancers

Kate Middleton Reaches Cancer Treatment Milestone

Breast Cancer Incidence Increased Due to Particulate Air Pollution, According to NIH Study.

Insurance Claim Denials for Preventive Care More Common in At-Risk Patients

Recommended Articles For You

Immuno-Oncology in Daily Practice: Transforming Cancer Care One Patient at a Time

Engineered Red Blood Cell Therapeutics: Emerging Applications

Case Study: Diagnostic and Therapeutic Challenges in Aplastic Anemia Mimicking Hypoplastic Myelodysplastic Syndrome

Unleashing the Inner Predator: Reprogramming Macrophages to Conquer Cancer Immunotherapy

Whats more on Hidoc Dr.

Medical Updates

KOL Videos

Surveys

Events

Featured News

Featured Articles

Featured Events

Featured KOL Videos

Quick Links

Verification

Welcome to Hidoc Dr.